Myasthenia Gravis (MG) Treatment Industry Forecast to 2030: A $2.5 Billion Market Dominated by Alexion Pharma, Grifols, Avadel Pharma, Novartis, Pfizer, AbbVie, and Roche
17 avr. 2024 04h05 HE
|
Research and Markets
Dublin, April 17, 2024 (GLOBE NEWSWIRE) -- The "Myasthenia Gravis Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ResearchAndMarkets.com's...
Global Myasthenia Gravis Treatment Market Forecast and Trends 2023-2028, Featuring Profiles of AbbVie, Bausch Health, Gilead Sciences, Merck, Servier and Teva
18 déc. 2023 06h43 HE
|
Research and Markets
Dublin, Dec. 18, 2023 (GLOBE NEWSWIRE) -- The "Global Myasthenia Gravis Treatment Market: Forecast and Trends" report has been added to ResearchAndMarkets.com's offering. The global market for...
Myasthenia Gravis Treatment Market Size, Share & Growth Analysis, [2028] | With CAGR of 7.5%
06 déc. 2023 07h28 HE
|
Fortune Business Insights
Pune, India, Dec. 06, 2023 (GLOBE NEWSWIRE) -- Global Myasthenia Gravis Treatment Market Size was valued at USD 1.15 billion in 2020 and is projected to grow from USD 2.03 billion by 2028 exhibiting...
Myasthenia Gravis Market is Projected to Boost at a Moderate Growth Rate by 2032, Estimates DelveInsight | Leading Companies - DAS-MG, Catalyst, Cabaletta Bio, Janssen, Argenx, UCB Pharma, Alexion, Immunovant
25 oct. 2023 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, Oct. 25, 2023 (GLOBE NEWSWIRE) -- Myasthenia Gravis Market is Projected to Boost at a Moderate Growth Rate by 2032, Estimates DelveInsight | Leading Companies - DAS-MG, Catalyst,...
Myasthenia Gravis Treatment Market is forecasted to reach USD 2.6 Billion by 2032, growing at a 7.3% CAGR from 2023 to 2032
03 oct. 2023 11h12 HE
|
Acumen Research and Consulting
LOS ANGELES, Oct. 03, 2023 (GLOBE NEWSWIRE) -- The Global Myasthenia Gravis Treatment Market Size accounted for USD 1.3 Billion in 2022 and is projected to achieve a market size of USD 2.6 Billion...
Myasthenia Gravis Treatment Market to Reach $3.1 Billion, Globally, by 2032 at 6.5% CAGR: Allied Market Research
15 mai 2023 21h00 HE
|
Allied Market Research
Portland, OR, May 15, 2023 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, "Myasthenia Gravis Treatment Market by Drug class (Monoclonal antibodies, Intravenous...
Myasthenia Gravis Treatment Market Size [2022-2029]: $2.03 Billion by 2028 at CAGR of 7.5%
26 mai 2022 06h26 HE
|
Fortune Business Insights
Pune, India, May 26, 2022 (GLOBE NEWSWIRE) -- The global myasthenia gravis treatment market size is anticipated to reach USD 2.03 billion by 2028 and exhibit a CAGR of 7.5% during the forecast...
Myasthenia Gravis Treatment Market Size [2022-2028] worth USD 2.03 billion | Exhibit a CAGR of 7.5%
28 févr. 2022 08h14 HE
|
Fortune Business Insights
Pune, India, Feb. 28, 2022 (GLOBE NEWSWIRE) -- The global myasthenia gravis treatment market size is anticipated to reach USD 2.03 billion by 2028 and exhibit a CAGR of 7.5% during the forecast...
Recent Clinical Trials Analysis on Myasthenia Gravis Treatment
22 juil. 2021 20h00 HE
|
DelveInsight Business Research LLP
Los Angeles, USA, July 22, 2021 (GLOBE NEWSWIRE) -- Recent Clinical Trials Analysis on Myasthenia Gravis Treatment Around 15+ key companies are developing the Myasthenia Gravis therapies. Argenx...